The global foot and ankle devices market size was valued at USD 4.2 billion in 2022 and is expected to register a compound annual growth rate (CAGR) of 6.9% from 2023 to 2030. The market is anticipated to offer lucrative development opportunities owing to the growing geriatric population, the emergency need for user-centric foot & ankle devices, the rising demand for minimally invasive surgical procedures, the increasing use of advanced technologies such as AI and robotics, and the prevalence of target diseases such as osteoporosis. Moreover, rising road accidents and sports-related injuries are propelling product demand. The COVID-19 pandemic disrupted the industry.
To stop the spread of the virus, residents were encouraged to stay at home during the pandemic. Individuals’ participation in physical activity was impacted by legally enforced constraints on their freedom of movement, with a reported increase in obesity cases and a decrease in the number of foot and ankle surgeries. According to an article published by the National Institute of Health (NIH) in January 2021, it was determined that COVID-19 had a significant impact on orthopedic surgeries. Only 230 (13.8%) of the 1661 trauma cases that were conducted during the 33 weeks under study involved foot and ankle injuries. These injuries made up 15.2% (147 out of 967) of all injuries before the lockdown, 8.8% (17 out of 193) during the lockdown, and 13.2% (66 out of 501) after.
Thus, during the pandemic, there was a significant decline in the number of foot and ankle trauma cases. The product demand is further fueled by an increase in traffic accidents and sports-related injuries. Globally, an ankle sprain is the most frequent injury. Around 628,000 sprains happen annually and 40% of sprain and strain injuries are caused by playing football. The rising prevalence of target diseases such as osteoporosis causes fractures by causing a decrease in bone density; this increases product demand. According to the International Osteoporosis Foundation, every 3 seconds, a fracture occurs due to osteoporosis, which accounts for more than 8.9 million fractures annually worldwide.
Throughout the world, the disease affects 6.3% of males over 50 years of age and 21.2% of women over the same age range. This implies that roughly 500 million women and men across the globe may be affected. Market expansion is supported by the introduction of new products that are using new technologies, such as 3D printing, in the production of implants simulating anatomical structures. In addition, key players are contributing to extensive R&D and seeking approval from regulatory bodies for manufacturing safe and effective devices. For instance, in February 2021, Additive Orthopaedics announced the approval of its Patient-Specific Talus Spacer by the U.S. Food and Drug Administration (FDA) for the treatment of avascular necrosis of the talus.
The orthopedic fixation products segment accounted for the largest revenue share of 33.1% in 2022. The need for orthopedic fixation is growing due to the rising incidence of ankle fractures. It is the most frequent form of lower extremity fracture in adults, accounting for 3.9-10.2% of fractures. In addition, the rising adoption of branded orthopedic devices due to their superior quality and lower risk of Surgical Site Infection (SSI) in developing nations, combined with the increasing number of new product launches, is anticipated to fuel segment development. For instance, in July 2022, Paragon 28, Inc. announced the launch of its Gorilla Central Column Plating System, which offers plates and equipment that can be used separately for Charcot instances or acute or chronic midfoot applications.
The soft tissue orthopedic devices segment will register the fastest CAGR over the forecast period. The primary cause of soft tissue or muscle damage is sports injuries. Athletes tend to injure their Anterior Cruciate Ligament (ACL) during sports or any sort of physical activity, such as workouts & training. Thus, the rising prevalence of sports-related injuries is expected to drive the segment. According to Statistics Canada, an average of 35% of injuries occur while a person is participating in a sport or fitness activity. Also, there are various products focused on orthopedic tissue repair available in the market. For instance, in May 2022, Paragon 28, Inc. launched TenoTac 2.0TM Soft Tissue Fixation System. The new product achieves optimum fixation of soft tissue to the bone to reduce pain and stiffness of the minor toes by using a titanium-threaded implant and a straightforward insertion technique.
The trauma segment accounted for the largest share of 35.5% of the overall revenue in 2022. Strains or tears in the muscles or tendons may result in foot and ankle trauma. Quick twists, slips, and falls cause bone fractures or breaks. Foot- and ankle-related traumas are also caused by vehicle accidents. Advancing age can make elderly people more susceptible to these types of injuries. In addition, improper sports training is another significant contributing factor in such instances. According to an article published by the National Institute of Health (NIH), in 2020, around 40 to 50 million major surgeries in trauma will be performed annually in the USA and 20 million in Europe, for a startling total of 310 million worldwide.
The Osteoarthritis (OA) segment is anticipated to register the fastest CAGR during the forecast period. Osteoarthritis is one of the most common chronic long-term joint disorders. Globally, the growing aging population, rising cases of lifestyle diseases, and a rise in OA cases are all expected to fuel the segment expansion. According to the Centers for Disease Control and Prevention (CDC), 54.4 million U.S. adults, or 1 in 4, have some type of arthritis; by 2040, this number is expected to rise to 78 million. Although there are more than 100 different types of arthritis, OA, which affects 32.5 million U.S. adults, is the most widespread variety.
North America dominated the global industry in 2022 and accounted for the maximum share of more than 48.75% of the overall revenue. The main factors responsible for this region’s significant share are the high incidence of injuries related to sports & physical activities and the presence of a large geriatric population pool. According to America’s Health Rankings Senior Report, in the U.S., more than 56 million adults, or roughly 16.9% of the total population, are aged 65 years and older. By 2050, this number is projected to rise to 85.7 million, or roughly 22% of the country’s total population.
In addition, the rising number of trauma centers established by the government that is equipped to deal with emergencies are factors contributing to the dominance of this region. Asia Pacific, on the other hand, is anticipated to register the fastest growth rate during the forecast period. The rapidly developing healthcare infrastructure in major countries, such as India, China, and Japan, and the rapidly expanding medical tourism industry are propelling the demand for ankle & foot devices in the region. The number of foot & ankle implantations performed in the region is increasing on account of the improved diagnostic tools as well as the rising incidence of chronic orthopedic ailments.
Key players are adopting various strategic initiatives, such as collaborations, signing of new partnership agreements, mergers & acquisitions, and geographic expansions, to strengthen their services and gain a competitive advantage over other companies. For instance, in February 2022, Johnson & Johnson subsidiary DePuy Synthes acquired CrossRoads Extremity Systems. By releasing technologically advanced goods, established companies are also bolstering their positions. Regulatory organizations like the U.S. FDA and the European CE mark are authorizing technologies that satisfy all requirements for clinical data and other safety standards. For instance, in December 2022, Enovis Corp. received FDA approval for STAR Patient Specific Instrumentation for use with the company’s STAR total ankle replacement device. Some of the prominent players in the global foot and ankle devices market are:
Stryker Corp.
Johnson & Johnson (De PuySynthes)
Zimmer Biomet Holdings, Inc.
Smith & Nephew plc
Össur
Enovis
Acumed, LLC
Arthrex, Inc.
Paragon 28
Orthofix
Report Attribute |
Details |
Market size value in 2023 |
USD 4.5 billion |
Revenue forecast in 2030 |
USD 7.1 billion |
Growth rate |
CAGR of 6.9% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered |
Product, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; India; Japan; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa, Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Stryker Corp.; Johnson & Johnson (De PuySynthes); Zimmer Biomet Holdings, Inc.; Smith & Nephew plc; Össur; Enovis; Acumed, LLC; Arthrex, Inc.; Paragon 28; Orthofix |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global foot and ankle devices market report on the basis of product, application, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Bracing and Support
Joint Implants
Soft Tissue Orthopedic Devices
Orthopedic Fixation
Prosthetics
Application Outlook (Revenue, USD Million, 2018 - 2030)
Hammertoe
Trauma
Osteoarthritis
Rheumatoid Arthritis
Neurological Disorders
Bunions
Osteoporosis
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global foot and ankle devices market size was estimated at USD 4.2 billion in 2022 and is expected to reach USD 4.5 billion in 2023.
b. The global foot and ankle devices market is expected to grow at a compound annual growth rate of 6.9% from 2023 to 2030 to reach USD 7.1 billion by 2030.
b. North America dominated the foot and ankle devices market with a share of 48.8% in 2022. The main causes of this region's significant market share are its high incidence of sporting & physical activity induced injuries and its sizable geriatric population.
b. Some key players operating in the foot and ankle devices market include Stryker Corporation, Johnson & Johnson (De PuySynthes), Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Össur, Enovis, Acumed, LLC, Arthrex, Inc., Paragon 28, and Orthofix
b. Key factors that are driving the market growth include lucrative development opportunities, owing to the growing geriatric population, the emergency need for user-centric foot and ankle devices, the rising demand for minimally invasive surgical procedures, increasing use of advanced technologies such as AI and robotics, and the prevalence of target diseases such as osteoporosis.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.